alkenes has been researched along with Carcinoma, Non-Small Cell Lung in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coiffard, L; Jacquot, C; Juge, M; Moreau, D; Roussakis, C; Roussis, V; Tomasoni, C | 1 |
| Carbonnelle, D; Jacquot, C; Papaconstadinou, A; Roussakis, C; Roussis, V; Tomasoni, C | 1 |
| de Jong, RS; de Vries, EG; Groen, HJ; Höppener, FJ; Mulder, NH; Sleijfer, DT; Uges, DR; van der Graaf, WT; Willemse, PH | 1 |
| Briand, G; Calogeropoulou, T; Carbonnelle, D; Jacquot, C; Lanco, X; Le Dez, G; Roussakis, C; Tomasoni, C; Tsotinis, A | 1 |
1 trial(s) available for alkenes and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.
Topics: Adult; Aged; Alanine Transaminase; Alkenes; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Half-Life; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Polyenes; Pyrones; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1999 |
3 other study(ies) available for alkenes and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Proliferation arrest in G1 phase of a non-small cell lung cancer cell line (NSCLC-N6) treated by an original compound methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate (VT1) independently of the p53/p21 cascade.
Topics: Alkenes; Benzoates; Carcinoma, Non-Small-Cell Lung; Cell Division; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Enzyme Inhibitors; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2003 |
Identification of a novel putative non-coding RNA involved in proliferation arrest of a non-small cell lung carcinoma cell line treated with an original chemical substance, methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate.
Topics: Adaptor Proteins, Signal Transducing; Alkenes; Base Sequence; Benzoates; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; G1 Phase; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Introns; Lung Neoplasms; Molecular Sequence Data; Oligoribonucleotides, Antisense; Phosphoproteins; RNA, Untranslated | 2004 |
Up-regulation of a novel mRNA (NY-CO-1) involved in the methyl 4-methoxy-3-(3-methyl-2-butenoyl) benzoate (VT1)-induced proliferation arrest of a non-small-cell lung carcinoma cell line (NSCLC-N6).
Topics: Alkenes; Antigens, Neoplasm; Antineoplastic Agents; Benzoates; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Division; Cell Size; DNA-Binding Proteins; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Nucleocytoplasmic Transport Proteins; Oligonucleotides, Antisense; Replication Protein A; RNA, Messenger; Tumor Cells, Cultured; Up-Regulation | 2001 |